Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ABLNYSE:NXRTNASDAQ:OACCNYSE:TINV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABLAbacus Life$8.42-3.9%$7.94$6.34▼$12.40$815.50M0.14203,101 shs296,766 shsNXRTNexPoint Residential Trust$34.58-4.0%$36.94$30.98▼$48.37$874.46M1.14132,404 shs107,169 shsOACCOaktree Acquisition Corp. III Life Sciences$10.44-0.4%$10.26$9.95▼$10.85$234.12MN/A102,593 shs445,667 shsTINVTiga Acquisition$24.31+2.2%$19.94$8.23▼$15.63$838.70M-0.02105,946 shs1.55 million shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABLAbacus Life-3.88%-5.50%+4.47%+11.08%-25.16%NXRTNexPoint Residential Trust-3.85%-2.80%-3.96%-11.64%-5.22%OACCOaktree Acquisition Corp. III Life Sciences-0.38%-0.19%+3.57%+4.40%+1,043,999,900.00%TINVTiga Acquisition+2.23%+2.01%+24.16%+34.38%+154.55%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABLAbacus Life3.0864 of 5 stars3.63.00.00.02.01.71.9NXRTNexPoint Residential Trust4.9242 of 5 stars4.05.02.52.72.84.21.3OACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/AN/AN/ATINVTiga AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABLAbacus Life 3.14Buy$14.0867.26% UpsideNXRTNexPoint Residential Trust 2.00Hold$44.2527.95% UpsideOACCOaktree Acquisition Corp. III Life Sciences 0.00N/AN/AN/ATINVTiga Acquisition 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest OACC, NXRT, ABL, and TINV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2025NXRTNexPoint Residential TrustCitizens JmpSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform5/19/2025NXRTNexPoint Residential TrustJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Perform5/15/2025NXRTNexPoint Residential TrustRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform5/13/2025NXRTNexPoint Residential TrustCompass PointSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Neutral$50.00 ➝ $42.505/9/2025ABLAbacus LifePiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$11.50 ➝ $12.004/29/2025ABLAbacus LifeMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$14.004/8/2025ABLAbacus LifePiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$13.00 ➝ $11.503/20/2025NXRTNexPoint Residential TrustRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$50.00 ➝ $44.003/10/2025NXRTNexPoint Residential TrustJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$41.00 ➝ $43.003/10/2025NXRTNexPoint Residential TrustTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$41.00 ➝ $42.00(Data available from 5/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABLAbacus Life$134.58M6.06$0.38 per share22.04$2.59 per share3.25NXRTNexPoint Residential Trust$255.34M3.42$4.98 per share6.94$19.26 per share1.80OACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/ATINVTiga AcquisitionN/AN/A$1.41 per share17.30($1.43) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABLAbacus Life$9.52M-$0.23N/A11.23N/A-11.65%12.88%6.51%N/ANXRTNexPoint Residential Trust$44.26M-$1.2819.7612.442.3417.54%9.54%2.29%7/29/2025 (Estimated)OACCOaktree Acquisition Corp. III Life SciencesN/AN/A0.00∞N/AN/AN/AN/AN/ATINVTiga Acquisition$23.19MN/A0.00∞N/AN/A-36.88%-2.91%N/ALatest OACC, NXRT, ABL, and TINV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025ABLAbacus Life$0.16$0.18+$0.02$0.05$39.51 million$44.14 million4/29/2025Q1 2025NXRTNexPoint Residential Trust$0.78$0.84+$0.06$0.84$63.29 million$63.22 million3/27/2025Q4 2024ABLAbacus Life$0.13$0.16+$0.03-$0.22$28.76 million$33.21 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABLAbacus LifeN/AN/AN/AN/AN/ANXRTNexPoint Residential Trust$2.045.90%N/AN/A 3 YearsOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/ATINVTiga AcquisitionN/AN/AN/AN/AN/ALatest OACC, NXRT, ABL, and TINV DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/29/2025NXRTNexPoint Residential Trustquarterly$0.515.57%6/16/20256/16/20256/30/20252/25/2025NXRTNexPoint Residential Trustquarterly$0.515.06%3/14/20253/14/20253/31/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABLAbacus Life0.651.291.29NXRTNexPoint Residential Trust3.251.791.79OACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/ATINVTiga AcquisitionN/A0.020.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABLAbacus LifeN/ANXRTNexPoint Residential Trust76.61%OACCOaktree Acquisition Corp. III Life SciencesN/ATINVTiga Acquisition54.49%Insider OwnershipCompanyInsider OwnershipABLAbacus Life79.20%NXRTNexPoint Residential Trust15.36%OACCOaktree Acquisition Corp. III Life SciencesN/ATINVTiga Acquisition4.52%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABLAbacus Life8296.85 million20.10 millionOptionableNXRTNexPoint Residential Trust325.29 million22.11 millionOptionableOACCOaktree Acquisition Corp. III Life SciencesN/A22.43 millionN/AN/ATINVTiga AcquisitionN/A34.50 million32.94 millionNot OptionableOACC, NXRT, ABL, and TINV HeadlinesRecent News About These CompaniesTiga Acquisition (NYSE:TINV) Stock Price Up 1.3% - Time to Buy?May 5, 2025 | marketbeat.comAfter TigaTx Acquisition, Epsilogen Exploring Pan-Isotype Antibody StrategiesApril 11, 2025 | precisionmedicineonline.comEpsilogen acquires TigaTx to expand pan-isotope cancer antibody pipelineApril 9, 2025 | msn.comArmada’s BEAT Music Fund buys stake in catalog of DJ and producer TigaMarch 26, 2025 | musicbusinessworldwide.comWhy This Dating App Stock Is Popping Off Over 300% TodayNovember 18, 2022 | benzinga.comLGBTQ Social Media Platform And Dating App Grindr Lands SPAC Deal: What Investors Should KnowMay 9, 2022 | benzinga.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesD-Wave Pushes Back on Short Seller Case With Strong EarningsBy Nathan Reiff | May 14, 2025View D-Wave Pushes Back on Short Seller Case With Strong Earnings3 Underrated Stocks Quietly Delivering Big GainsBy Thomas Hughes | May 13, 2025View 3 Underrated Stocks Quietly Delivering Big GainsMicrosoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock WinsBy Chris Markoch | May 15, 2025View Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock WinsOklo Reaches Critical Mass, Atomic Upside Still AvailableBy Thomas Hughes | May 14, 2025View Oklo Reaches Critical Mass, Atomic Upside Still Available3 Industry Behemoths Are Rewarding Investors With Dividend BumpsBy Leo Miller | April 28, 2025View 3 Industry Behemoths Are Rewarding Investors With Dividend BumpsOACC, NXRT, ABL, and TINV Company DescriptionsAbacus Life NASDAQ:ABL$8.42 -0.34 (-3.88%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$8.42 0.00 (0.00%) As of 05/21/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Abacus Life, Inc. operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.NexPoint Residential Trust NYSE:NXRT$34.58 -1.46 (-4.04%) Closing price 05/21/2025 03:59 PM EasternExtended Trading$34.54 -0.04 (-0.11%) As of 05/21/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NexPoint Residential Trust is a publicly traded REIT, with its shares listed on the New York Stock Exchange under the symbol "NXRT," primarily focused on acquiring, owning and operating well-located middle-income multifamily properties with "value-add" potential in large cities and suburban submarkets of large cities, primarily in the Southeastern and Southwestern United States. NXRT is externally advised by NexPoint Real Estate Advisors, L.P., an affiliate of NexPoint Advisors, L.P., an SEC-registered investment advisor, which has extensive real estate experience.Oaktree Acquisition Corp. III Life Sciences NASDAQ:OACC$10.44 -0.04 (-0.38%) As of 05/21/2025 03:57 PM EasternOaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.Tiga Acquisition NYSE:TINV$24.31 +0.53 (+2.23%) As of 05/20/2025Tiga Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is headquartered in Singapore. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Could Rally as EU Antitrust Case Nears Resolution Canada Goose Soars 30%—Is This Rally Built to Last? Palo Alto Networks: Buy The Dip, Long-Term Tailwinds Ahead Lowe’s Stock Uptrend Can Continue for These 2 Reasons CrowdStrike Near Breakout: Is Now the Time to Buy? $30B AI Opportunity: Will It Power Meta’s Next Surge? Intel Refocuses: NEX Sale and Foundry Pivot Signal New Era Rivian Stock Below $20: Charging Up or in the Breakdown Lane? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
